Graeme Eisenhofer

Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results

Graeme Eisenhofer, David S. Goldstein, McClellan M. Walther et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 491 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma

Henri Timmers, Clara C. Chen, Jorge A. Carrasquillo et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 393 citations · Full text

Medicine, Nuclear Medicine, Radiology +15

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

Graeme Eisenhofer, Jacques W.M. Lenders, Gabriele Siegert et al. · European Journal of Cancer · 2011 · 374 citations · Full text

Medicine, Biochemistry, Oncology +14

Superiority of Fluorodeoxyglucose Positron Emission Tomography to Other Functional Imaging Techniques in the Evaluation of Metastatic <i>SDHB</i>-Associated Pheochromocytoma and Paraganglioma

Henri Timmers, Anna Kozupa, Clara C. Chen et al. · Journal of Clinical Oncology · 2007 · 336 citations · Full text

Medicine, Oncology, Radiology +17

<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

Nelly Burnichon, Alberto Cascón, Francesca Schiavi et al. · Clinical Cancer Research · 2012 · 327 citations · Full text

Life Sciences, Genetics, Oncology +14